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Identiﬁcation of renin progenitors in the mouse
bone marrow that give rise to B-cell leukaemia
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The cell of origin and triggering events for leukaemia are mostly unknown. Here we show that
the bone marrow contains a progenitor that expresses renin throughout development and
possesses a B-lymphocyte pedigree. This cell requires RBP-J to differentiate. Deletion of RBP-J
in these renin-expressing progenitors enriches the precursor B-cell gene programme and
constrains lymphocyte differentiation, facilitated by H3K4me3 activating marks in genes that
control the pre-B stage. Mutant cells undergo neoplastic transformation, and mice develop a
highly penetrant B-cell leukaemia with multi-organ inﬁltration and early death. These renin-
expressing cells appear uniquely vulnerable as other conditional models of RBP-J deletion do
not result in leukaemia. The discovery of these unique renin progenitors in the bone marrow
and the model of leukaemia described herein may enhance our understanding of normal and
neoplastic haematopoiesis.
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R
enin cells have traditionally been associated with the
regulation of blood pressure and ﬂuid-electrolyte home-
ostasis. Pursuing the mechanisms that regulate the identity
of these cells, we uncovered an unexpected property of renin cells
in the bone marrow with relevance to the development of
malignancy. Renin progenitors appear early in the embryo and
give rise to many different cell types throughout the body1.
Whereas the function of renin cells in extra renal tissues is
unclear, the ontogeny and function of renin cells in the kidney are
better understood2–5. In the embryonic kidney, renin precursors
are distributed extensively along nephrovascular units and
participate in the assembly and branching morphogenesis of the
kidney arterioles. As development of the kidney proceeds, renin
precursors differentiate in situ into arteriolar smooth muscle cells,
glomerular mesangial cells and interstitial pericytes. Thus, in the
adult only a few cells at the tip of the renal arterioles near the
glomeruli, the juxtaglomerular (JG) cells, retain the ability to
synthesize and secrete renin upon physiological demands1. Under
normal conditions, those cells sufﬁce to regulate blood pressure
and ﬂuid-electrolyte homeostasis. However, if such adult animal
is subjected to a homeostatic threat (such as hypotension,
dehydration, sodium depletion or administration of renin–
angiotensin inhibitors), there is an increase in the number of
renin-expressing cells along the arterioles, glomeruli and
interstitium, resembling the embryonic pattern described
above6,7. This phylogenetically conserved process occurs by
re-transformation of arteriolar smooth muscle cells, mesangial
cells and pericytes into renin-expressing cells1,8.
Because renin cells contain all the components of the Notch
pathway including RBP-J, the ﬁnal transcriptional effector of all
the Notch receptors9, and Notch/RBP-J is known to regulate cell
fate, we previously examined whether deletion of RBP-J
regulates the identity and plasticity of kidney renin cells
during normal development and in response to a physiological
threat. Conditional deletion of RBP-J in renin-expressing cells
resulted in a decrease in the number of renin-positive JG cells in
the kidney and an inability of smooth muscle cells along the
kidney vasculature to regain the renin phenotype10.
Unexpectedly, as these mice aged beyond 6 months, they
developed signs and symptoms of a highly penetrant and
fulminant form of precursor B-lymphoblastic leukaemia. Given
the potential medical relevance of this ﬁnding, in this study we
perform an extensive series of experiments to fully characterize
this mouse model of leukaemia, including its natural history and
the genomic and epigenetic events underlying its development.
We also set out to identify, and characterize in detail, which cells
in the bone marrow are capable of producing renin under
normal circumstances and whether those cells may be the origin
of this striking model of leukaemia. Finally, we ascertain
whether mutations in the RBP-J gene are associated with
leukaemia in humans as well. We ﬁnd that renin is expressed by
a subset of B-cell progenitors in the mouse bone marrow, and
that these renin-expressing cells are the cell of origin for B-cell
leukaemia when RBP-J is deleted.
Results
Deletion of RBP-J in renin cells results in B-cell leukaemia. We
deleted RBP-J in cells of the renin-lineage by crossing mice that
express Cre recombinase under control of the renin locus with
RBP-Jﬂ/ﬂ mice1,10,11. Mutant mice (RBP-Jﬂ/ﬂ; Ren1dcre/þ )
developed progressive abdominal distension and poor overall
health by B6 months of age (Fig. 1a). Necropsy demonstrated
massive hepatosplenomegaly (spleen and liver weights were
15- and 4-fold higher than controls, respectively) (Fig. 1a–d).
Mutant animals displayed marked leukocytosis and anaemia
(Fig. 1e), lymph node tumour formation (74% of mutant mice
developed axillary or retroperitoneal tumours) (Fig. 1f), and
succumbed at an early age with a median survival of 269 days
(Fig. 1g).
Blood smears from mutant mice demonstrated a predomi-
nance of lymphoblasts (Fig. 2a). Flow cytometry of bone marrow
and tumours conﬁrmed the presence of an aberrant B-lymphoid
(B220dim/CD19þ ) immunophenotype at the expense of myeloid
cells compared with control mice (Fig. 2b). The phenotype was
indicative of precursor B-cell leukaemia evidenced by the lack of
IgM and IgD expressions (Fig. 2c). Similar ﬁndings were found in
the spleen and peripheral blood of leukaemic animals
(Supplementary Fig. 1a–c).
Given the presence of lymphoblasts within the blood and bone
marrow and the extensive organomegaly, we performed a
comprehensive histologic evaluation of mutant and control mice.
The spleens of mutant mice were massively inﬁltrated with
lymphoblasts resulting in defacement of their normal architecture
without recognizable red or white pulp (Fig. 2d). Lymphoblasts
invaded the liver in a periportal and perisinusoidal distribution
(Fig. 2e) and kidney interstitium (Supplementary Fig. 2a). Mutant
mice developed skin lesions (characterized by loss of fur, nodules
and ulcerations due to epidermal and dermal lymphoblastic
inﬁltration) and lymphoid tumours (Supplementary Fig. 2b,c).
Finally, bone marrow from leukaemic animals was hypercellular
compared with controls and consisted of a homogenous blast
population that occupied over 90% of marrow space (Fig. 2f).
These blasts replaced other haematopoietic cells explaining the
marked anaemia found in mutant animals. Lymphoblasts
displayed diffuse and strong immunoreactivity for PAX5 and
CD79a, further conﬁrming a B-cell lineage and expressed TdT
and CD34 supporting a B-cell precursor maturational stage
(Supplementary Fig. 2d–g).
To follow the distribution of mutant cells, we bred our mutant
and control mice with mT/mG reporter mice, which normally
express RFP in all cells but GFP only in cells that express Cre
recombinase. Therefore, cells harbouring the RBP-J deletion are
GFPþ , whereas non-mutant leukocytes are RFPþ 12. The
number of GFPþ cells was markedly elevated in the blood and
organs of mutant mice (Fig. 2g), indicating that deletion of RBP-J
causes B-cell leukaemia with expansion of lymphoblasts to the
bloodstream and invasion and morphological distortion of
peripheral organs.
Following the current classiﬁcation of murine lymphoid
neoplasms, the majority (92%) of mutant mice (n¼ 22)
developed precursor B-cell lymphoblastic lymphoma/leukaemia
(pre-B LBL)13. A minority (8%) of mice (n¼ 2) was affected by a
myeloproliferative or mixed lymphoid/myeloid disorder and
three animals developed mild disease. Given the striking
predominance of the pre-B LBL, we focused our efforts on a
detailed characterization of this phenotype.
We performed multiple experiments to investigate if this
leukaemia model represents a clonal process and if the leukaemic
cells can grow in a cell-autonomous manner in culture and
transplant systems. First, analysis of immunoglobulin gene
rearrangements was performed to determine the clonal nature
of leukaemic cells. These studies demonstrated that B cells from
the spleen and bone marrow of mutant animals had unique
patterns of V(D)JH rearrangements when compared with wild-
type animals, with a predominant recombination indicating
mono- or oligo-clonal IgH patterns (Supplementary Fig. 3a–c).
Next, we performed colony-forming assays from bone marrow
cells of mutant mice to determine the clonogenic potential of
leukaemic cells. Whereas wild-type bone marrow did not form
colonies beyond the ﬁrst passage, leukaemic cells continue to
grow even after extensive passaging. At the time of writing this
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Figure 1 | Deletion of RBP-J in renin-lineage cells leads to tumour development and early death. (a) Mutant mice (right in both panels) develop
abdominal distension compared with control mice (left in both panels) and necropsy demonstrated that abdominal distension was due to
hepatosplenomegaly. (b) Representative picture of enlarged spleen from mutant mouse (right) compared with control (left). (c) Representative picture of
the enlarged liver from mutant mouse (right) compared with control (left). (d) Leukaemic mice have statistically signiﬁcant increased body, spleen and liver
weights compared with control mice. Student’s t-test; ***Po0.001 (n¼ 11 for control mice and n¼ 14 for mutant mice). (e) The white blood cell (WBC)
count is signiﬁcantly higher and haemoglobin lower in leukaemic mice compared with controls. The platelet count is not signiﬁcantly different between
control and leukaemic mice. Horizontal lines represent the mean for each group in panels d-e. Student’s t-test; ***Po0.001 (n¼ 11 for both control mice
and mutant mice). (f) Lymphomatous tumours (yellow asterisks) at lower extremities, abdomen, anterior neck and upper extremities. Tumours were
commonly found in the retroperitoneum just anterior to the vertebral column. (g) Kaplan–Meier survival curve showing early death of leukaemic mice
compared with control mice.
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manuscript, the leukaemic cell lines continue to be passaged, with
one line currently beyond 25 passages, over 6 months (Fig. 3a,b).
This cell line that expresses GFP (we bred mutant mice with mT/
mG reporter mice) was chosen for extended analysis in transplant
and gene expression studies. Deletion of RBP-J in this cell line was
conﬁrmed by PCR. To test whether those leukaemic cells are
transplantable, GFPþ cells from the aforementioned colonies
were injected into the tail vein of irradiated host animals. At 1
week post injection, recipient animals were killed and organs were
collected. While irradiated recipients that did not receive
leukaemic cell injections had severely hypoplastic bone marrow,
animals that received injections of leukaemic cells had a nearly
normocellular marrow almost entirely composed of transplanted
GFPþ leukaemic cells (Fig. 3c). Further, leukaemic cells
inﬁltrated multiple other organs including the spleen, lung,
kidney, thymus and gonads as determined by the presence of
massive numbers of GFPþ cells (Supplementary Fig. 4). Finally,
GFPþ leukaemic cells from the bone marrow of transplanted
recipient animals were recovered and placed back into culture.
The cells continue to grow in methycellulose, currently at passage
6, demonstrating the aggressive and resilient nature of these cells
(Fig. 3a). Together, these studies indicate that deletion of RBP-J in
renin cells results in leukaemic transformation as evidenced by
clinical assessment, histologic evaluation, ﬂow cytometry analysis,
immunoglobulin rearrangements, colony-forming assays and
transplantation studies.
Renin cells in haematopoietic organs are precursor B cells. To
investigate the cell of origin and identity of the renin-expressing
cell in the bone marrow and spleen, we used several strategies.
First, we employed lineage tracing: we crossed Ren1dcre/þ mice
with mT/mG reporter mice that after Cre-mediated recombina-
tion express GFP in cells that expressed renin12. Fluorescence
imaging demonstrated GFPþ cells from the renin lineage in the
spleen (Fig. 4a) and bone marrow (Fig. 4b), conﬁrming the
presence of cells from the renin lineage within these
haematopoietic organs. RT–PCR conﬁrmed the presence of
renin mRNA in the bone marrow from control mice
(Supplementary Fig. 5a).
Next, we performed methylcellulose colony assays to deﬁne
the conditions that would best permit the growth and expansion
of renin-lineage cells. Cells from the bone marrow of
Ren1dcre/þ ;mT/mG mice were cultured under conditions permis-
sive of either myeloid-erythroid or B-lymphocyte growth: cells
from the renin lineage (GFPþ cells) had a growth advantage in
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Figure 2 | Deletion of RBP-J in renin-lineage cells results in cell autonomous precursor B-cell leukaemia with inﬁltration of multiple organs. (a) May–
Grunwald Giemsa-stained blood smears from control and mutant mice at low and high power. Scale bars equal 100mm (top row) and 20mm (bottom row).
(b) Representative ﬂow cytometric analysis of bone marrow. Control mice (left column) show 14.4% B cells with normal immunophenotype (B220þ
CD19þ , top), 30% granulocytes (Gr1þ CD11bþ , bottom) and 37% immature myeloid cells (GR1 CD11bþ ). Leukaemic mice (middle column) show a
signiﬁcant reduction in normal B cells (0.4%), granulocytes (5.3%) and immature myeloid cells (4.8%), and a markedly expanded population of
lymphoblasts (89%) with aberrant dim B220 expression (B220Dim CD19þ ). (c) Representative ﬂow cytometric analysis of bone marrow from control and
leukaemic mice demonstrating arrest of B-cell maturation. Control marrow contains 0.16% of common lymphocyte progenitors (Lin IL7Raþ ) compared
withB0% in leukaemic marrow (left column). Control marrow contains 2.6% of pro B cells (B220þ CD43þ ) and 7% of B220þCD43 B cells (middle),
that correspond 43% to pre B cells (B220þ CD43 IgM IgD), 22% to immature B cells (B220þ CD43 IgMþ IgD) and 33% to mature B cells
(B220þ CD43 IgMþ IgDþ) (right). The leukaemic marrow has a large population of B220þ CD43þ cells (73%) (middle) similar to a pro B-cell
population, and minimal IgM or IgD expression marking the lymphoblasts as precursor B-cell leukaemia (right). (d) Haematoxylin and eosin staining of
spleen sections from control and mutant mice. Scale bar, 500mm. (e) Haematoxylin and eosin staining of liver sections from control and mutant mice. Scale
bar, 100mm. (f) Low and high magniﬁcation of bone marrow. Scale bar, 500mm (top row) and 50mm (bottom row). Insets show higher magniﬁcation of
lymphoid cells (d–f). (g) Fluorescence of peripheral blood from control and mutant mice with mT/mG reporter demonstrates expansion of the GFPþ -cell
population in mutant mice. Scale bar, 100mm.
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B-cell media versus myeloid-erythroid media suggesting
again that renin-lineage cells are mostly B cells (Supplementary
Fig. 5b–d). We also observed GFPþ GEMM colonies in the
myeloid-erythroid medium suggesting that a small number of
renin precursors have myeloid potential and may be responsible
for the less frequent myeloproliferative disorder we observed in a
small proportion of the animals.
To determine the immunophenotype of renin cells within the
bone marrow, we performed ﬂow cytometry. Bone marrow cells
from Ren1c-YFP (YFP labels cells actively transcribing renin)14 and
Ren1dcre/þ ;mT/mG mice (GFP labels cells, which throughout
their history have expressed or continue to express renin) were
obtained and stained for lineage markers of B lymphocytes,
T lymphocytes and myeloid cells and analyzed by ﬂow cytometry.
These studies demonstrated that the large majority of marrow cells
that either actively express renin (YFPþ cells) or are descendants
from the renin-producing cells (GFPþ cells) express markers of B
cells (B220, CD19, IgM) with reduced expression of myeloid (Gr1
and CD11b) or T-cell (CD3) markers (Fig. 4c,d). YFPþ cells had
o10% IgM expression suggesting that renin expression occurs in
early B-lymphocyte progenitors, whereas GFPþ cells had B60%
IgM expression reﬂecting the normal maturation of
renin-expressing B-lineage cells within the bone marrow. In both
sets of experiments, the YFP and GFP cells represented a
normal distribution of wild-type bone marrow (Fig. 4e).
Additional ﬂow strategies were performed to determine the
stage of development of renin-expressing and renin-lineage cells.
We quantiﬁed the number of common lymphocyte progenitors
(Lin IL7Raþ ), Pro-B cells (B220þCD43þ ), Pre-B cells
(B220þ IgM IgD ), Immature B-cells (B220þ IgMþ IgD ),
and Mature B-cells (B220þ IgMþ IgDþ ) in both Ren1c-YFP
and Ren1dcre/þ ;mT/mG mice (Fig. 4f). Further, we investigated
the classically deﬁned B-cell developmental subsets in the bone
marrow (Hardy fractions A-F)15 and found that renin is
expressed mostly by Fraction B cells (Supplementary Fig. 6).
Collectively, these studies demonstrated that cells that are actively
expressing renin are Pro-B cells, while renin-lineage cells, as
expected, encompass premature, immature and mature B cells
(Fig. 4f and Supplementary Table 1).
Given that RBP-J deletion occurs in B cells that currently
express or previously expressed renin (provisionally, we
denominated this cell as ‘Brenin-cell’), we determined the relative
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Figure 3 | Leukaemic cells grow in culture and are transplantable into irradiated mice. (a) Mutant animals expressing GFP (RBP-Jﬂ/ﬂ;Ren1dcre/þ ;mTmG)
developed leukaemia as described. When animals became moribund, necropsy was performed and bone marrow cells were collected for culture in
methylcellulose. Cultured leukaemic cells are GFPþ, have deletion of RBP-J, have gene expression patterns similar to leukaemic spleens and can be serially
passaged over many months. Leukaemic cells from culture were then injected into irradiated wild-type mice with engraftment and inﬁltration of GFPþ -
leukaemic cells. Bone marrow cells were recovered from transplanted animals and continued to grow in methylcellulose culture. (b) Leukaemic cells grow
as colonies in methylcellulose culture. The population of leukaemic cells is homogenous. Scale bar, 200mm. (c) In non-irradiated mice, leukaemic cells
failed to engraft following intravenous injection. These animals had normocellular bone marrow (top row) and almost no presence of GFPþ cells (0 to 4
GFPþ cells per bone marrow section). Irradiated animals that received only injection of vehicle control (media) had markedly hypocellular bone marrow
(second row) and absence of GFPþ cells. Animals that received irradiation and injection of leukaemic cells had a mildly hypocellular bone marrow (third
row) with almost all of the marrow cells expressing GFP (bottom row) demonstrating engraftment of leukaemic cells (n¼ 3). Scale bar, 200mm (left
column) and 100mm (right column).
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contribution of renin-expressing cells to the cell endowment
of the bone marrow and spleen at different developmental
stages. We sorted cells currently expressing renin (YFPþ ) and
cells from the renin-lineage (GFPþ ) isolated from the bone
marrow and spleen of Ren1c-YFP and Ren1dcre/þ ;mT/mG
mice described above. The fraction of renin-expressing and
renin-lineage cells decreases with age both in the bone marrow
and spleen (Fig. 4g,h). Thus, renin cells constitute a distinct
subset of the total B-lymphocyte population, and their numbers
diminish with age.
Given the high percentage of renin-lineage cells in the spleen
(B25% shortly after birth), we performed multiple experiments
to further characterize the identity and stage of maturation of
these cells. First, we collected spleens of Ren1dcre/þ ;mT/mG
reporter mice, stained sections with IgM antibody and evaluated
by immunoﬂuorescence. These studies demonstrated that GFPþ
cells in the spleen (renin-lineage) are predominantly located in
the follicles, and that they represent both marginal zone (IgM
bright) and follicular (IgM dim) B cells (Fig. 5a). Further, splenic
B cells from Ren1dcre/þ ;mT/mG mice were analysed by ﬂow
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cytometry for expression of B220, CD21 and CD23. We found
that GFPþ cells in the spleen include both marginal zone
(B220þ /CD21Hi/CD23Lo) and follicular (B220þ /CD21Int/
CD23Hi) B cells (Fig. 5b), and further conﬁrmed by staining
with B220, IgM and IgD that GFPþ cells mark both marginal
zone (IgMHi/IgDLo) and follicular (IgMLo/IgDHi) B cells (Fig. 5c).
Next, to deﬁne whether Brenin-cells respond to a decrease in
angiotensin II as the classical kidney renin cells, we treated
Non-renin lineage Renin lineage IgM Overlay
x100
x200
x400
RFP
CD
21
Ig
D
IgMCD23
GFP RFP
39%
31.8% 39.7%
40.7%
GFP
19.5% 43.4% 43.1%35.1%
Figure 5 | Renin cells in the spleen represent both marginal zone and follicular B cells. (a) Fluorescence images of spleens from Ren1dcre/þ ;mT/mG
mice. GFPþ cells (renin-lineage) localize to the follicles of the spleen and largely co-localize with IgM. Scale bar, 200mm (top row), 100mm (middle row)
and 50mm (bottom row). (b) Flow cytometry on splenocytes from Ren1dcre/þ ;mT/mG mice demonstrating that renin-lineage cells (GFPþ) express cell
surface antigens consistent with both marginal zone (CD21HiCD23 ) and follicular (CD21IntCD23þ ) B cells (gates are on B220þ cells). (c) Flow
cytometry on spleen cells from Ren1dcre/þ ;mT/mG mice conﬁrming that renin-lineage cells (GFPþ) express cell surface antigens consistent with both
marginal zone (IgMHiIgDLo) and follicular (IgMLoIgDHi) B cells (gates are on B220þ cells).
Figure 4 | Renin cells represent a small and diminishing population of B lymphocytes. (a) Low (left) and high (right) magniﬁcation ﬂuorescence
images of spleens from Ren1dcre/þ ;mT/mG mice. Scale bar, 100 mm (left) and 50mm (right). (b) Bright-ﬁeld (left) and ﬂuorescence (right) images of the
bone marrow from Ren1dcre/þ ;mT/mG mice showing the presence of GFPþ renin-lineage cells. Scale bar, 50mm. (c) Representative ﬂow cytometry on
the bone marrow from Ren1dcre/þ ;mT/mG mice demonstrating that renin-lineage cells (GFPþ) express cell surface antigens most consistent with B cells
(92% B220þ , 96% CD19þ and 61% IgMþ ) with minimal staining for markers of myeloid (o1% CD11bþ and Gr1þ ) and T (o10% CD3þ ) cells.
(d) Representative ﬂow cytometry on bone marrow from Ren1c-YFP transgenic mice demonstrating that renin-expressing cells (YFPþ) are precursor
B cells (85.5% B220þ , 79.7% CD19þ ) with minimal staining for markers of more mature B cells (8.3% IgMþ ), myeloid cells (5.8% CD11bþ and 4.3%
Gr1þ ) and T cells (0% CD3þ ). (e) A comparison of YFP versus YFPþ (top) and GFP versus GFPþ (bottom) cell immunophenotypes in the bone
marrow of Ren1c-YFP and Ren1dcre/þ ;mT/mG reporter mice. Error bars represent s.e.m. (n¼ 2 for renin-expressing (Ren1c-YFP) experiments and n¼4
for renin-lineage (Ren1dcre/þ ;mT/mG) experiments). (f) Top panel: renin-lineage cells from the bone marrow were evaluated for cell surface markers
consistent with common lymphocyte progenitors (Lin IL-7Raþ ), pro-B cells (B220þ CD43þ ), premature B cells (B220þ CD43 IgM IgD),
immature B cells (B220þ CD43 IgMþ IgD) and mature B cells (B220þ CD43 IgMþ IgDþ). This strategy demonstrated that renin-lineage cells are
B0.01% common lymphocyte progenitors,o5% pro-B cells,B33% premature B cells,B24% immature B cells, andB34% mature B cells. Bottom panel:
renin-expressing cells were evaluated using the same strategy. This demonstrated that renin-expressing cells are predominantly (81.3%) pro-B cells
with smaller populations of common lymphocyte progenitors (4.77%), pre-B cells (10.9%), immature B cells (6.8%) and mature B cells (0.95%).
Images are representative of experiments performed in triplicate. (g) The percentage of renin-expressing (YFPþ) cells within the bone marrow and spleen
was quantitated over time using Ren1c-YFP mice and ﬂow cytometry. Shortly, after birth, mice hadB0.2% renin-expressing cells. However, this percentage
decreased with age in both the spleen and marrow to B0.01%. n¼8 for bone marrow samples and n¼ 5 for spleen samples. (h) The percentage of
renin-lineage (GFPþ) cells within the bone marrow and spleen of Ren1dcre/þ ;mT/mG mice as measured by ﬂow cytometry. The percentage of renin-lineage
cells decreases from B20% shortly after birth to B2% at 200 days of life in the bone marrow. n¼ 12 for both bone marrow and spleen samples.
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Bac-ren-GFP mice16 (here GFP identiﬁes cells currently
synthesizing renin) with the angiotensin-converting enzyme
inhibitor captopril and observed by ﬂow cytometry a 2.5-fold
increase in the percentage of renin-expressing cells in the bone
marrow (Supplementary Fig. 7a). Similarly, mice with deletion of
the Ren1d gene (Ren1dcre/cre;mT/mG) showed an increase in the
number of circulating GFPþ cells (Supplementary Fig. 7b),
suggesting a recruitment of renin progenitors and their
descendants both in the bone marrow and the circulation.
Finally, we performed microarray analysis on renin-expressing
cells sorted from the bone marrow isolated from Bac-ren-GFP
mice. In addition to high expression of renin (53-fold enrichment
when corrected for presorted cells), these cells displayed
high expression of transcripts characteristic of precursor
B lymphocytes including early B-cell factor (Ebf1, 13.9-fold),
immunoglobulin lambda chain variable 1 (Iglv1, 13.8-fold),
recombination-activating gene 1 (Rag1, 7.0-fold), pre-B-lympho-
cyte gene 3 (Vpreb3, 5.6-fold) and numerous other lymphocyte-
speciﬁc transcripts displayed in abbreviated form in Table 1.
Thus, in agreement with the lineage tracing, colony-forming
capacity and immunophenotyping, the microarray analysis
indicated that normal renin-expressing cells in the bone marrow,
the cells of origin for this type of lymphoid leukaemia, are
B-lymphocyte progenitors.
RBP-J deletion in renin cells enriches a B-cell gene programme.
We next investigated how deletion of RBP-J in renin-lineage cells
affects the molecular programmes regulating lymphopoiesis and
contributes to leukaemogenesis. Given that the spleens of mice
Table 1 | Gene expression proﬁle of Brenin cells.
Top genes
Up
Fold
change
Symbol Gene name
2 53.6 Ren1/
Ren2
Renin
21 13.9 Ebf1 Early B-cell factor 1
22 13.8 Iglv1 Immunoglobulin lambda chain,
Variable 1
49 10.8 Foxo1 Forkhead Box O1
161 7.1 Sox4 SRY-box containing gene 4
173 7.0 Ikzf3 IKAROS family zinc family 3
175 7.0 Rag1 Recombination activating gene 1
197 6.7 Dtx1 Deltex 1 homologue
304 5.6 Vpreb3 Pre-B-lymphocyte gene 3
355 5.2 Pax5 Paired box gene 5
605 4.0 Rag2 Recombination-aActivating gene 2
1024 3.1 Rag1ap1 Rag1 activating protein 1
Table 2 | Enrichment of a B-cell gene programme and epigenetic changes in leukaemic spleens.
Fold
change
Symbol Gene name Mutant versus control
H3K4me3*
Mutant versus control
H3K27me3w
Upregulated genes
44.4 Igll1 Immunoglobulin lambda-like polypeptide 1 50.903 0.400
27.3 Enpep Glutamyl aminopeptidase 32.289 0.446
11.9 Rag1 Recombination-activating gene 1 15.310 0.898
10.3 Vpreb1 Pre-B-lymphocyte gene 1 68.980z 0.587
9.9 Rag2 Recombination-activating gene 2 7.970 0.455
6.9 Vpreb3 Pre-B-lymphocyte gene 3 5.729 0.948
4.5 Gpam glycerol-3-phosphate acyltransferase, mitochondrial 1.414 1.376
4.2 Erg Avian erythroblastosis virus E-26 (v-ets) oncogene
related
0.742 0.887
3.9 Cd93 CD93 Antigen 5.928 0.307
3.9 Atp1b1 ATPase, Naþ /Kþ transporting, beta 1 polypeptide 1.448 0.648
4.0 Sox4 SRY-box containing gene 4 1.547 1.249
3.4 Ppm1e Protein phosphatase 1E (PP2C domain containing) 2.047 0.450
3.4 Eps8 Epidermal growth factor receptor pathway substrate 8 2.289 0.565
2.6 Myb Myeloblastosis oncogene 1.947 0.486
2.2 Ebf1 Early B-cell factor 1 1.280 0.619
1.7 E2A Transcription Factor E2A (Tcf3) 1.740 1.337
Downregulated genes
5.3 Cd7 CD7 antigen 0.117 1.379
4.1 Ccr9 Chemokine (C-C motif) receptor 9 0.897 1.520
4.0 Art2b ADP-ribosyltransferase 2b 0.109 1.056
4.0 Faim3 Fas apoptotic inhibitory molecule 3 0.191 1.880
3.9 Dtx1 Deltex 1 homologue 0.101 4.086
3.8 Ctsw Cathepsin W 0.227 0.948
3.6 Cr2 Complement receptor 2 0.677 0.623
3.5 Tcf7 Transcription factor 7, T-cell speciﬁc 0.198 1.802
2.8 Cd4 CD4 antigen 0.096 1.259
2.8 Lat Linker for activation of T cells 0.243 1.706
2.8 Icos1 icos ligand 0.188 6.590
2.5 Tbx21 T-box 21 0.119 1.516
2.4 Runx3 Runt-related transcription factor 3 0.093 2.615
*The H3K4me3 mutant versus control ratio was determined using the average fragment density over the promoter ( 2,500 bp to þ 2,500bp relative to the transcription start).
wThe H3K27me3 mutant versus control ratio was determined using the average fragment density over the gene body and ﬂanking regions (the gene region plus 2,500 bp upstream to 5,000 bp
downstream).
zFor Vpreb1 the H3K4me3 average fragment density is limited to  500bp toþ 500bp relative to the transcription start to discriminate the Vpreb1 signal from that of the nearby gene, Top3b.
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with leukaemia were enlarged over 15-fold due to massive
inﬁltration with leukaemic cells, we performed microarray
analysis on RNA isolated from whole spleens of control and
leukaemic mice. In mice with B-cell leukaemia, genes involved in
growth and differentiation of early lineage B cells (Ebf1, Sox4),
immunoglobulin gene rearrangements (Vpreb1, Igll1, Rag1, Rag2)
or cell division (Myb) were markedly upregulated (Table 2),
whereas genes that either control or are characteristic of T lym-
phocytes (Tcf7, Tbx21, Art2b, CD4, CD7, Ccr9) were repressed
when compared with control mice (Table 2). We validated the
mRNA expression levels for these genes by quantitative RT–PCR
(qRT–PCR) and found that the qRT–PCR and microarray data
expression proﬁles were highly correlated (Fig. 6a,b). In the
mutant, the levels of Igll1, Enpep, Rag1, Vpreb1 and Vpreb3 as
measured by qRT–PCR were even more elevated (1,410-, 73-, 59-,
1,131- and 13–fold, respectively) than in the microarray array
data, suggesting that the microarray detection had reached
saturation for these transcripts. Further, we performed qRT–PCR
from a pure population of cultured GFPþ leukaemic cells and
found a similar pattern of upregulation of genes marking early
B-cell development including VpreB1, Igll1 and VpreB3
(Supplementary Fig. 8).
To obtain a comprehensive view of the changes in the
chromatin landscape in the leukaemic cells, we performed
genome-wide ChIP-Seq analysis of chromatin from whole spleens
of control and leukaemic mice using antibodies against H3K4me3
(a marker of gene activation) and H3K27me3 (a marker of gene
suppression). There was remarkable congruence between this
ChIP-Seq data and the mRNA array data. Table 2 shows the
ratios of the average fragment density (Mutant versus Control)
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Figure 6 | Deletion of RBP-J in renin-expressing haematopoietic precursors enriches the B-cell genetic programme. (a) Validation by qRT–PCR of the
differentially expressed genes in RNA from control and mutant spleens. Genes involved in early B-cell development and in T-cell and NK-cell commitment
showed a remarkable difference in expression between mutant and control spleens. Error bars are s.e.m. (n¼ 5 for each condition). Student’s t-test
*Po0.05; ***Po0.001. (b) Log2 values of fold changes in gene expression as measured by qRT–PCR and microarray analyses. The expression proﬁles were
highly similar between qRT–PCR and microarray data. Igll1 and VpreB1 levels in the mutants are substantially higher by qRT–PCR measurements than in the
array, which is likely due to the saturation of the signal in the array.
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for H3K4me3 over the promoter from  2,500 bp to þ 2,500 bp
relative to the transcription start and for H3K27me3 over the
gene body plus 2,500 bp upstream and 5,000 bp downstream. The
H3K4me3 activating marks are enriched on promoters of
the upregulated genes, while there is little or no enrichment of
the H3K27me3 suppressive marks. The genes downregulated in
the mRNA array have diminished H3K4me3-activating marks
and enrichment of H3K27me3 suppressive marks. Figure 7 shows
the pattern of modiﬁcations on the upregulated genes validated
previously by qRT–PCR. The highly upregulated genes in the
mutant cells display increased presence of the H3K4me3
activation mark on the promoter and, in the case of Vpreb1,
Vpreb3 and Igll1, throughout the gene (Fig. 7). In wild-type cells,
these genes have low or no occupancy of activating marks.
Further, the H3K27me3 suppressive mark is consistently lower
than the activation mark in the mutant. In summary, the mRNA
array, qRT–PCR and ChIP-Seq results demonstrate that genes
important for commitment to early B-cell development are
markedly upregulated, whereas genes associated with other
haematopoietic lineages are repressed when compared with
control mice. Thus, deletion of RBP-J in renin-expressing
haematopoietic precursors leads to enrichment of precursor
B-lineage genes at the expense of alternative cell fates, a process
facilitated by epigenetic changes.
Gene set enrichment analysis (GSEA) is a computational
method that determines whether deﬁned gene signatures are
differentially expressed between two groups17. Using a canonical
pathway knowledge database containing 880 known gene sets, we
performed GSEA on our gene expression data comparing the
expression pattern in spleens from mice with leukaemia versus
control mice. Cells from mice with leukaemia were enriched in
gene signatures associated with cell cycle progression
(Supplementary Fig. 9a and Supplementary Table 2). Flow
cytometry conﬁrmed that mutant cells have an increased
percentage of cells in the S and G2/M phases compared with
control cells, indicating enhanced cell division as a result of RBP-J
deletion (Supplementary Fig. 9b,c). Further, phosphohistone H3
staining showed a higher number of cells undergoing
proliferation in leukaemic versus control mice (Supplementary
Fig. 9d,e). These results indicate that deletion of RBP-J promotes
cell cycle progression and cellular proliferation in B cells.
Together, these results show that silencing of RBP-J in renin-
expressing cells restricts the lineage potential of these progenitors
to a precursor B-cell fate and alters the regulation of cell cycle
progression ultimately leading to leukaemic transformation.
Mutations of RBP-J in patients with lymphoid malignancies.
Given the striking ﬁndings encountered in our mice, we investi-
gated whether mutations of RBP-J are present in human hae-
matological malignancies. We performed RBP-J exon sequencing
in 44 patients with conﬁrmed haematopoietic malignancies
(Supplementary Table 3). A total of 10 patients (23%) had var-
iants in the coding region of RBP-J (Supplementary Table 4). We
identiﬁed nine different predicted missense mutations and two
frameshift deletions (Supplementary Fig. 10a). One deletion
recurred in ﬁve patients, causing a frameshift at position 188 of
the coding region, which is predicted to result in a 104 amino-
acid truncated protein. These variants occurred in highly con-
served regions of RBP-J and are novel as none of them were found
in a large number of normal genomes including 1000 Genomes
Project, NCBI Single-Nucleotide Polymorphism database
(dbSNP) and NHLBI Exome Sequencing Project (ESP5400).
Finally, many of the missense variants are predicted to be
damaging to the protein product as determined by multiple
prediction models including AVSIFT, SIFT, PolyPhen2, LRT and
Mutation Taster (Supplementary Table 4). Of note, RBP-J
variants occurred in both B-cell and myeloid malignancies
(Supplementary Fig. 10b).
Discussion
Mice with deletion of RBP-J in renin cells develop precursor
B-cell leukaemia. The cell of origin for this leukaemia is a novel
renin-expressing haematopoietic progenitor with a B-lymphocyte
pedigree, which we have termed the Brenin-cell. Deletion of RBP-J
in these precursors leads to enrichment of the genetic programme
for B-cell commitment, enhanced cell cycle progression and
proliferation, inﬁltration of multiple organs and early death.
Leukaemic cells have clonal IgH rearrangements, can be cultured
for multiple passages, are transplantable in irradiated animals and
can be recovered from recipient mice and further grown in
culture.
To our knowledge, this is the ﬁrst report demonstrating RBP-J
silencing as an initiating event in B-cell leukaemogenesis. Radke
et al.18 showed that deletion of Notch1 in adult bone marrow
results in enhanced B-cell development, but not overt leukaemia.
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Figure 7 | Chromatin proﬁles of genes activated in the mutant leukaemic spleen. The proﬁles depict the ChIP-Seq signals for H3K4me3 (green) and
H3K27me3 (red) modiﬁcations in mutant (MUT) and wild-type (WT) spleens. The x axis for all genes is in KB with the scale indicated by the bar
below each gene. The y axis corresponds to the number of sequenced ChIP fragments that overlap a given position. The highly upregulated genes in the
mutant all display increased occupancy of the H3K4me3 activation mark on the promoter and, in the case of Vpreb1, Vpreb3 and Igll1, throughout the
gene. In contrast, in the WT those genes have low or no occupancy of activating marks. The H3K27me3 suppressive mark is consistently lower than the
activation mark in the MUT.
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Han et al.11 used Mx-Cre mice to delete RBP-J in adult bone
marrow cells resulting in blockade of T-cell development and
increase in B-cell development within the thymus, but not
leukaemia. Finally, Tanigaki et al.19 deleted RBP-J in B-cells by
targeting the B-cell lineage marker CD19, leading to enhanced
follicular B-cell populations with loss of marginal zone B-cells but
no leukaemia phenotype. Remarkably, deletion of RBP-J in Brenin-
cells leads to overt leukaemia suggesting that these renin-
expressing cells are particularly vulnerable to transformation.
However, we have not excluded the possibility that the precursor
B leukaemia observed in the current study reﬂects strain
differences in our mice compared with other conditional
models of RBP-J deletion that do not result in leukaemia.
The existence of a local bone marrow renin-angiotensin system
(RAS) has previously been described20. Components of the RAS
are present in bone marrow cells with putative roles in both
normal and neoplastic haematopoiesis21–24. While the presence
of renin in the bone marrow has been suggested, the identity and
function of renin cells during haematopoiesis were unknown. In
our study, we found that Brenin-cells decrease fromB20 toB1%
in the normal bone marrow and fromB20 toB5% in the spleen
by 6 months of age. Further, a related member of the RAS,
angiotensin-converting enzyme (ACE), has been well
characterized as a marker of haematopoietic stem cells during
both fetal and adult life25,26. It is therefore possible that Brenin-
cells may be remnants of embryonic haematopoiesis or that renin
marks a speciﬁc stem cell population with differential
transforming capacity, accounting for the difference between
models27, and suggesting that the phenotype caused by loss of
RBP-J in haematopoietic cells depends on the cell of origin.
Together with previous studies, our ﬁndings suggest that renin
and the RAS may play critical roles in haematopoietic ontogeny
and HSC plasticity.
We found remarkable developmental, biochemical/ transcrip-
tional and functional similarities between the Brenin-cell and its
seemingly more distant kidney renin cell. Similar to their kidney
cell counterpart, Brenin-cells in the bone marrow and spleen also
decrease in number as development proceeds and are responsive
to physiological challenges: captopril treatment as well as life-time
deletion of the Ren1d gene disturbs circulatory and ﬂuid-
electrolyte homeostasis and induce an increase in GFPþ cells
in the bone marrow and the circulation indicating that renin-
expressing haematopoietic cells respond to systemic and/or local
physiological cues, such as lack of angiotensin, in a manner not
dissimilar to the JG cell6. Brenin-cells and JG renin cells also share
numerous transcriptional regulators, notably EBF1, a known
regulator of lymphocyte development, members of the Notch
pathway including ligands and receptors and the ﬁnal
transcriptional effector, RBP-J14. These observations suggest
conservation of the regulatory machinery and a possible lineage
relationship between the two cell types. The functional relevance
of these ﬁndings is underscored by the fact that both cell types
need RBP-J to differentiate and function properly: lack of RBP-J
in kidney renin cells results in a signiﬁcant decrease in the
number of renin cells and loss of the descendant’s memory to
regain the renin phenotype. Similarly, mutant Brenin-cells lose
their differentiation potential, are retained in a precursor stage
and lose control of their normal cell cycle leading to neoplastic
transformation. In both cases, RBP-J regulates cell fate.
What is the local function of renin precursors in these two
tissues? In the kidney, renin cells control vascular development28–31.
Although components of the renin–angiotensin system have been
described in peripheral leukocytes22 and bone marrow23, the
function of renin cells in haematopoietic tissues remains to be
determined. It would be interesting to determine whether Brenin
cells also participate in the coordinated systemic response to control
circulatory and ﬂuid-electrolyte homeostasis, or whether renin
expression in the bone marrow serves some other role during
primitive, deﬁnitive and neoplastic haematopoiesis23.
In this study, we found cooperative mechanisms for leukaemic
transformation: upregulation of genes involved in B-cell speciﬁ-
cation and of genes involved in cell cycle progression. During
normal haematopoiesis, Notch/RBP-J signalling favours T-cell
development by repressing a network of transcription factors
important for early B-cell commitment including EBF1 and
E2A27,32–34. These transcription factors in turn are responsible
for activating transcription of several genes critical for early B-cell
development, including Igll1, Rag1 and Vpreb1 (ref. 35). Deletion
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Figure 8 | Depiction of this model of lymphoblastic leukaemia. Normal B-cell development proceeds from haematopoietic stem cells (HSC) through
multiple stages to ultimately become mature B cells. A small subset of pro-B cells express renin and are termed BRenin-cells. In this model, activation of the
renin promoter in BRenin-cells results in cre recombinase expression and subsequently RBP-J deletion. These cells fail to differentiate along the normal
B-cell pathway, undergo epigenetic activation and enrichment of a precursor B-cell gene programme. Mutant cells additionally experience cell cycle
progression and cell proliferation ultimately resulting in expansion of a lymphoblast population and the development of precursor B cell leukaemia.
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of RBP-J in renin cells led to increased expression of those
B-lineage associated transcripts. These ﬁndings were correlated
with ChIP-Seq data. H3K4me3 activating marks, which facilitate
the opening of the chromatin structure to permit transcription,
were present along those genes responsible for the pre B-cell
genetic programme. Of note are the highly overexpressed genes
Rag1, Vpreb1 and Vpreb3 that had H3K4 activation marks not
only in the promoter but also along the entire body of gene
reinforcing their open chromatin structure. In addition, the ChIP-
Seq data showed H3K27 repressive marks along genes from other
lineages. Thus de-repression of the determinants of B-lineage
commitment by deletion of RBP-J appears to restrict progenitors
to a precursor B-cell fate. Our array and GSEA analyses also
demonstrated enrichment of genes involved in cell cycle
progression. Genetic defects that cause a block in lymphocyte
differentiation and progression of the G1/S cell cycle transition
have been reported in lymphocytic leukaemia36,37. Similar to
these ﬁndings, deletion of RBP-J in Brenin-cells leads to cell cycle
progression and increased cellular proliferation, tissue inﬁltration
and early death.
Mutations of RBP-J in humans have not been extensively
studied: we could ﬁnd only one report of an RBP-J sequence
mutation occurring in a haematologic malignancy38. Schuh et al.38
performed whole-genome sequencing to track the subclonal
evolution of chronic lymphocytic leukaemia in three patients
over different treatment time points. They identiﬁed a mutation
occurring in RBP-J in a single patient, and, similar to our ﬁndings,
this variant was present at a low frequency (1.16 to 6.69% over
different time points). To further explore whether mutations in
RBP-J contribute to human disease, we sequenced the exome of
RBP-J in 44 bone marrow specimens from patients with
haematopoietic malignancies. We found that a fraction of B-cell
malignancies contained single-nucleotide variants in the coding
regions of RBP-J. These variants occurred in conserved regions of
the gene, have not previously been seen in a large number of
healthy individuals and are predicted to have negative translational
consequences. In addition, we detected RBP-J variants in myeloid
leukaemia samples that support previous work demonstrating
inactivating mutations of the Notch pathway in patients with
chronic myelomonocytic leukaemia39. Several limitations of this
study are worth noting. First, we did not have remission samples
from these patients to conﬁrm the somatic nature of these
mutations. Second, the bone marrow samples likely included a
mixed population of cells including normal haematopoietic cells
and heterogeneous malignant subclones, which may have
inﬂuenced the low variant allele frequency. However, the
signiﬁcant occurrence of these RBP-J variants in a variety of
haematologic malignancies in this and the aforementioned study38
and the fact that these variants have not been previously detected
in healthy individuals suggest that mutations of RBP-J should be
further studied to deﬁne whether they indeed contribute to disease
development, maintenance or progression in humans.
In summary, we identiﬁed novel bone marrow progenitors,
which express renin and become the source of lymphoblastic
leukaemia when RBP-J is missing (Fig. 8). The possibility that
within the B-cell population there are subsets of progenitors with
differential transformative capacity has signiﬁcant implications for
understanding the origin of leukaemia. The discovery of these
progenitors, the reproducibility of this highly penetrant mouse
model of leukaemia, and the generation of a new GFP labelled
leukaemia cell line offer an invaluable opportunity to explore the
mechanisms responsible for normal and neoplastic haematopoiesis.
Methods
Generation of study mice. To inactivate RBP-J in renin-lineage cells, we crossed
Ren1dcre/þ mice1, which express Cre recombinase in renin cells, to RBP-J ﬂoxed
(RBP-Jﬂ/ﬂ) mice (a kind gift from T Honjo)11. Mice carrying both RBP-Jﬂ/ﬂ and
Ren1dcre/þ undergo Cre-mediated recombination speciﬁcally in cells that express
renin leading to deletion of RBP-J11,19. RBP-Jﬂ/þ ;Ren1dcre/þ mice were mated to
generate RBP-Jﬂ/ﬂ;Ren1dþ /þ (control) and RBP-Jﬂ/ﬂ;Ren1dcre/þ (mutant) mice.
For genotyping, genomic DNA was extracted and puriﬁed from tail biopsies using
Quiagen DNeasy Blood and Tissue kit (Valencia, CA) according to the
manufacturer’s instructions, and standard PCR was performed in an Eppendorf
thermocycler using Taq polymerase (Promega, Madison, WI). The primers used
for genotyping were: wild-type renin forward 50-GAAGGAGAG CAAAAGGTA
AGAG-30, wild-type renin reverse 50-GTAGTAGAAGGGGGAGTTGTG-30,
Ren1dcre forward 50-GAAGGAGAGCAAAAGGTAAGAG-30 , Ren1dcre reverse 50-
TTGGTGTACGGTCAGTAAATTGGAC-30 , wild-type RBP-J forward 50-GTTCT
TAACCTGTTGGTCGGAACC-30, wild-type RBP-J reverse 50-GCTTGAGGCTT
GATGTTCTGTAATGC-30 , ﬂoxed RBP-J forward 50-GTTCTTAACCTGTTGGTC
GGAACC-30 , and ﬂoxed RBP-J reverse 50-GCAATCCATCTTGTTCAATGGCC-30
(ref. 10). Lineage tracing was performed to determine the pattern of renin
expression in the bone marrow and spleen. Ren1dcre/þ mice were bred to the
lineage reporter line mT/mG12. In this reporter, non-recombined cells express RFP,
and following Cre-mediated recombination GFP is expressed in renin-lineage cells
and their descendants. This line was used to isolate renin-lineage cells in normal
mice and in mice with RBP-J deletion within renin cells. Ren1c-YFP transgenic
mice were used to isolate cells that actively express renin40. Finally, renin-
expressing cells in the bone marrow were isolated for gene array studies from
transgenic Bac-Ren1c-GFP mice16. Flow cytometry and immunoﬂuorescence
experiments involving renin-expressing and renin-lineage reporters were
performed on both male and female mice between the age of 2 weeks and 3
months. To determine the relative fraction of renin cells within the bone marrow
and spleen at different developmental stages, renin-expressing and renin-lineage
mice were evaluated at different ages between 2 weeks and 200 days of life.
Mutant mice were monitored until they developed signs and symptoms of
disease. When they became moribund, they were anaesthetized with tribro-
moethanol (300mg kg 1)41, and organs were removed, preserved for RNA
extraction, ﬁxed for immunohistochemistry or immunoﬂuorescence, or processed
for ﬂow cytometry. Twenty-four mutant mice are included in this study with equal
numbers of age-matched control animals. Study animals included both males and
females. All procedures were performed in accordance with the National Institutes
of Health guidelines for the care and use of laboratory animals and were approved
by The Animal Care and Use Committee of the University of Virginia.
Identiﬁcation of cell phenotypes by ﬂow cytometry. To determine the subtype
of leukaemia and characterize its cell of origin, ﬂow cytometry analysis was per-
formed. Single-cell suspensions were obtained from the bone marrow, spleen and
tumours found in the abdomen and axillary regions. To obtain bone marrow cells,
the long bones of mice were dissected, ﬂushed with cell suspension media
(Biolegends, San Diego, CA), and the cells were passed through a 70 mm strainer.
Spleens or tumours were dissected cleanly, placed on a 70 mm strainer and, using
the plunger end of a syringe, gently passed through the strainer. The tissue was
rinsed with cell staining buffer (CSB) (Biolegends) and the process repeated until
the spleen capsule turned clear. All cells were treated with RBC lysis buffer (Sigma,
St Louis, MO), resuspended in CSB, counted using a haemocytometer and dis-
tributed into microcentrifuge tubes for antibody labelling against the surface
markers in Supplementary Table 5 (all antibodies were purchased from Biolegends
except CD43, which was purchased from Becton Dickinson, Franklin Lakes, NJ).
Antibodies were added at predetermined optimum concentrations (Supplementary
Table 5) and incubated at room temperature for 20min. Immunophenotyping was
performed in the UVA Flow Cytometry core lab using a Fortessa cytometer and
data analysed with FlowJo program.
Identiﬁcation of RBP-J deletion in peripheral blood. To mark with GFP and
indirectly evaluate the deletion of RBP-J in circulating leukocytes, 0.5 ml of blood
from RBP-Jﬂ/ﬂ;Ren1dcre/þ ;mT/mG and RBP-Jþ /þ ;Ren1dcre/þ ;mT/mG mice was
obtained by a small cut of the tip of the tail, collected using heparinized pipette tips
and diluted in 100 ml of cold PBS in a 96-well plate. Using an inverted microscope
(Leica DMIRE2) recombined (GFPþ ) and not recombined (RFPþ ) cells were
counted in three ﬁelds using a  20 objective and pictures were taken using a
Retiga EXi camera (Q-Imaging, Surry, BC).
RNA extraction and PCR analysis. Total RNA was isolated from the whole bone
marrow, spleen and tumour samples using Trizol extraction (Life Technologies,
Grand Island, NY) according to the manufacturer’s instructions. cDNA was
prepared from 2 mg of RNA using Moloney murine leukaemia virus reverse
transcriptase (Life Technologies, Grand Island, NY) and an oligo(dT) primer
according to the manufacturer’s instructions. PCR was performed on 2 ml of cDNA
using Taq DNA polymerase (Promega, Madison, WI)40.
For validation of microarray data, qPCR was performed using SYBR Green 1
(Invitrogen Molecular Probes, Eugene, OR) in a CFXConnect system (Biorad,
Hercules, CA)42. Primers are listed in Supplementary Table 6.
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Histologic analysis. Immunohistochemistry was performed on Bouin’s and for-
malin-ﬁxed tissue. In brief, 5-mm tissue sections were deparafﬁnized in xylenes and
graded alcohols. Sections were incubated overnight with primary antibodies against
PAX5 (BD Clone 24/Pax5, dilution 1:40), CD79a (Dako Clone JCB117, dilution
1:400), TdT (Cell Marque polyclonal, ready to use), CD34 (Dako Clone QBEnd10,
dilution 1:100) and Phosphohistone H3 (Cell Signaling Technologies, dilution
1:200), and antibody binding was visualized using the Vectastain ABC kit (Vector
Laboratories, Burlingame, CA). Sections were counter-stained with haematoxylin,
dehydrated through graded alcohols to xylenes and mounted with Permount.
Immunoﬂuorescence was performed on frozen sections using a primary
antibody against IgM (Biolegends, dilution 1:10). Sections were washed with PBS
then blocked for 1 h using 10% BSA in PBS with 1% normal donkey serum.
The primary antibody was incubated overnight at 4 C then incubated with a
ﬂuorescently conjugated secondary antibody (AlexaFluor 350, Invitrogen, 1:500).
Immunoglobulin gene rearrangement analysis. Genomic DNA from the bone
marrow, spleen and tumour samples was used as templates for PCR ampliﬁcation.
Primer pairs used were DQ52 for 50-CCACAGGCTCGAGAACTTTAGCG-30 ;
JH4 Rev 50-AGGCTCTGAGATCCCTAGACAG-30 to detect D-J recombination
products; VH7183 for 50-GTGGAGTCTGGGGGAGGCTTA-30 ; JH4 Rev
50-AGGCTCTGAGATCCCTAGACAG-30 to detect V-DJ products; DLG5 for
50-AAGTCTCAGGCTGGCCATTA-30; DLG5 Rev 50-TTTACCACCCCTGAC
ACACA-30 to amplify a single-copy gene used for normalization of DNA
amount43. The PCR reaction was performed in a 50 ml volume containing 100 ng,
33 ng or 11 ng of template DNA, 1 PCR buffer, 1.5mM MgCl2, 0.2mM dNTPs,
0.4 mmM each primer and 0.75 U Taq polymerase (Promega Corporation,
Madison, WI). Thermocycling conditions were as follows: 4min at 95 C followed
by 31 cycles of 30 s at 95 C, 90 s at 60 C, 2min at 72 C and a ﬁnal extension step
of 5min at 72 C. Products (15 or 20ml of the PCR reaction) were separated on 1%
agarose gels, transferred to GeneScreen Plus Hybridization Transfer Membrane
(Perkin Elmer, Waltham, MA) and hybridized at 42 C to JH probe 50-TATG
GACTACTGGGGTCAAGGAA-30end labelled with 32P-ATP using 20 U of T4
polynucleotide kinase (New England Biolabs, Ipswich, MA). Membranes were
washed with 2 SSC, 0.1% SDS and exposed to Kodak Biomax MS ﬁlm.
Cell cycle analysis. The DNA content of ﬁxed cells from the bone marrow and
spleen was determined using propidium iodide (PI) staining44. Single-cell
suspensions from the spleen and bone marrow were obtained as described above.
The cells were counted using a haemocytometer, and 1 106 cells were ﬁxed and
stored in 70% ethanol at 4 C. On the day of cell cycle analysis, the ﬁxed cells were
resuspended in 5ml PBS, centrifuged 5min at 200 g and resuspended in 1ml of
PI staining solution (10ml of TritonX-100 PBS, 2mg DNase-free RNase A and
200ml of 1mgml 1 PI). Cells were incubated in PI solution for 30min at room
temperature, and DNA content was determined using ﬂow cytometry.
In vitro colony-forming assay. To determine the growth characteristics of renin-
lineage cells, bone marrow cells from Ren1dcre/þ ;mT/mG reporter mice were
grown in methylcellulose with medium permissive for either B-lymphocyte or
myeloid-erythroid colony growth (Methocult GF medium for mouse Pre-B cells,
M3630, and Methocult GF for mouse haematopoietic progenitors, M3434, Stem-
Cell Technologies Vancouver, BC, Canada). Cells were diluted in Iscove’s MDM
with 5% FBS, and plated in duplicate samples at 1 105 cells per 30mm plate.
After incubation for 14 days at 37 C in 5% humidiﬁed CO2, plates were visualized
using inverted microscopy (Leica DMIRE2) and colony-forming units (CFUs) were
scored according to standard criteria45. The percent of GFPþ (renin-lineage)
colonies was quantitated in both B-cell and myeloid/erythroid permissive culture
conditions.
Transplantation studies. Leukaemic B cells that express GFP were puriﬁed from
methylcellulose cultures and injected intravenously at a dose of 2–6 106 cells into
irradiated mice (13Gy) (n¼ 3). Recipients were monitored closely and killed at 1
week post injection. Control animals included non-irradiated mice that received
leukaemic cell injections, and irradiated mice that received vehicle only (media).
Gene expression analysis. RNA was isolated from spleens from mutant and
control mice. Hybridization to the Affymetrix mouse gene array ST1.0 was
performed by the UVA Core Lab Microarray Facility. All preprocessing and
analysis were done using R version 2.15.0. CEL ﬁles were imported using the
Affymetrix package, version 1.34.0. Expression intensities were summarized,
normalized and transformed using Robust Multiarray Average algorithm46.
Probesets were annotated using the BioConductor annotation package
mogene10sttranscriptcluster.db version 8.0.1, annotate package, version 1.34.0.
Linear models with empirical Bayes moderated standard errors were ﬁt using the
BioConductor limma package version 3.12.1. False discovery rate was used to
correct for multiple testing. Gene set enrichment analysis was used to examine
coordinated gene expression changes in canonical pathways using the Molecular
Signatures Database curated canonical pathway gene set17,47. GEO accession:
GSE46229.
RNA was extracted from renin-expressing bone marrow cells isolated from
Bac-Ren1c-GFP mice using a Becton-Dickinson Aria 2 cell sorter in the RPCI Flow
Cytometry Core Facility. RNA from unsorted bone marrow and GFPþ cells was
hybridized to MOE430 V2.0 oligonucleotide microarray GeneChip Arrays
(Affymetrix) in the RPCI Gene Expression Facility. The results from the three
replicates were normalized using RMA and quantile. GEO accession: GSE53916.
Chromatin immunoprecipitation and next generation sequencing. Chromatin
immunoprecipitation (ChIP-Seq) was performed by Active Motif (Carlsbad, CA).
Chromatin (30mg) from control and mutant spleens was precipitated with anti-
bodies against H3K4me3, a marker of active genes (2 ml, AM 39159) and
H3K27me3, a marker of inactive genes (4 ml, Millipore 17–449). ChIP DNA was
processed into Illumina libraries using standard procedures, and libraries were
sequenced on HiSeq 2000. The 50-nt sequence reads were mapped to the mouse
mm9 genome using the BWA algorithm with default settings. For the analysis, all
data ﬁles were normalized to the same number of unique alignments without
duplicate reads (17.5 million). Sequence tags were extended in silico (using Active
Motif software) at their 30-ends to a length of 200 bp. To identify the density of
fragments (extended tags) along the genome, the genome was divided into 32-nt
bins and the number of fragments in each bin was determined. The resulting
histogram ﬁles were used to extract average fragment density values for predeﬁned
promoter and gene regions. For H3K4me3, promoter regions from  2,500 bp to
þ 2,500 bp relative to the transcription start sites were used. However, for Vpreb1,
the promoter regions were restricted to  500 bp to þ 500 bp relative to the
transcription start site to discriminate Vpreb1 from the nearby gene, Top3b. For
H3K27me3, gene regions plus 2,500 bp upstream and 5,000 bp downstream
ﬂanking regions were used. In this approach, the same genomic segments are
compared between the Mutant and Control data sets, and the ratio of average
fragment densities is a valid metric for comparison. In parallel, genomic regions
with signiﬁcant enrichments in tag numbers were identiﬁed using the SICER peak
ﬁnding algorithm49 (cutoff FDR, 1E-10). Only genes with SICER peaks were
included in the ratio calculation described above and shown in the Table 2. GEO
accession: GSE46566.
RBP-J Sequencing in Human Bone Marrow Specimens. To identify mutations in
RBP-J that may be causing loss of function in human disease, we performed RBP-J
exon sequencing in the bone marrow from patients with haematopoietic malig-
nancies. Genomic DNA was isolated from 140 bone marrow samples using the
Qiagen DNAeasy kit, and 84 samples were suitable for sequencing. Amplicons were
designed Using TruSeq Custom Amplicon design studio to cover the coding
regions of RBP-J and exome enrichment was performed. After PCR ampliﬁcation,
each exon was sequenced using an Illumina MiSeq instrument with paired-end 151
base pair reads. Data were aligned using MiSeq Reporter version E. All variants that
were non-synonymous were evaluated for signiﬁcance. Of these 84 samples, 44
patients had a deﬁnitive diagnosis of haematopoietic malignancy available in their
medical record and were included in our analysis. These studies were approved by
the University of Virginia Institutional Review Board for Health Science Research.
The project met criteria of research involving coded biological specimens, and
informed consent was not required.
Statistical analysis. Data are presented as means±s.e.m. Signiﬁcance between
groups was determined using the Mann–Whitney U-test and two-tailed Student’s
t-test using GraphPad Prism 5.0. Differences were considered statistically sig-
niﬁcant at the *Po0.05; **Po0.01 and ***Po0.001 levels.
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